Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

GD-23 reduces anxiety by relying on neurosteroid production.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

Baricitinib successfully treated severe hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

An arthritis drug helped a person with severe hair loss regrow their hair.

Dried blood spots can be as stable as frozen liquid samples for storing certain metabolites.

Certain cancer drugs can cause skin issues like rashes and itching.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ozenoxacin reduces sebum production, helping manage acne.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.